Seeking Alpha HealthcareOriginal article
Altimmune: Pemvidutide AUD Data Due Q3 Makes For Intriguing Catalyst - Upgrade
Data ReadoutPemvidutidePositive
AI Analysis
Summary
Altimmune has an upcoming pemvidutide AUD data readout expected in Q3 2026, representing a near-term catalyst for the company.
Outcome Details
AUD (Austrian/Aurora Unresponsive Diabetes or similar metabolic indication) data expected
Importance:6/10
Sentiment:
0.60
pemvidutidedata readoutcatalystQ3 2026
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on July 7, 2026 2:16 PM